These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19789404)

  • 1. Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support.
    Vrtovec B; Radovancevic R; Delgado RM; Radovancevic B; Bracey AW; Gregoric ID; Frazier OH
    Eur J Heart Fail; 2009 Oct; 11(10):1000-4. PubMed ID: 19789404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and outcome after ventricular assist device placement.
    Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R
    Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and management of gastrointestinal bleeding with continuous flow assist devices.
    Aggarwal A; Pant R; Kumar S; Sharma P; Gallagher C; Tatooles AJ; Pappas PS; Bhat G
    Ann Thorac Surg; 2012 May; 93(5):1534-40. PubMed ID: 22541185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy.
    Bonde P; Ku NC; Genovese EA; Bermudez CA; Bhama JK; Ciarleglio MM; Cong X; Teuteberg JJ; Kormos RL
    Ann Thorac Surg; 2012 May; 93(5):1541-7; discussion 1547-8. PubMed ID: 22480391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal timing of cardiac transplantation after ventricular assist device implantation.
    Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices.
    Schulman AR; Martens TP; Christos PJ; Russo MJ; Comas GM; Cheema FH; Naseem TM; Wang R; Idrissi KA; Bailey SH; Naka Y
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):841-2. PubMed ID: 17320612
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycemia and prognosis of patients with chronic heart failure--subanalysis of the Long-term Prospective Randomized Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients (REMADHE) trial.
    Issa VS; Amaral AF; Cruz FD; Ayub-Ferreira SM; Guimarães GV; Chizzola PR; Souza GE; Bocchi EA
    Am Heart J; 2010 Jan; 159(1):90-7. PubMed ID: 20102872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild anaemia is associated with increased all-cause mortality in heart failure.
    Teng TH; Finn J; Hung J
    Heart Lung Circ; 2010 Jan; 19(1):31-7. PubMed ID: 19783210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, molecular, and genomic changes after left ventricular assist device implantation.
    Hetzer R; Dandel M; Knosalla C
    J Am Coll Cardiol; 2011 Jun; 57(24):2459-60; author reply 2460. PubMed ID: 21658572
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of renal function before mechanical circulatory support on posttransplant renal outcomes.
    Singh M; Shullo M; Kormos RL; Lockard K; Zomak R; Simon MA; Bermudez C; Bhama J; McNamara D; Toyoda Y; Teuteberg JJ
    Ann Thorac Surg; 2011 May; 91(5):1348-54. PubMed ID: 21524442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.
    Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F
    J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
    Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
    Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
    Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.